Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиLarimar Therapeutics Мультипликаторы 2011-2024 | LRMR
Мультипликаторы по годам Larimar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.3 | -4.3 | -1.5 | -3.5 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.8 | -1.4 | -3.0 | -3.6 | -1.2 | -1.9 | -1.9 | -2.1 | -2.8 | -3 | -19.5 | -19.6 | - |
EV (Enterprise Value) |
369 млн | 141 млн | 19 млн | 94.2 млн | 10.4 млн | -9.26 млн | -522 тыс. | -13.4 млн | -772 тыс. | -58.1 млн | -35.5 млн | -9.94 млн | - |
EBITDA per Share |
-0.94 | -1.41 | -2.92 | -4.55 | -4.84 | -22.7 | -23.1 | -25.5 | -33.1 | - | - | - | - |
EV/EBITDA |
-0.3 | -2.4 | 0.2 | 0.4 | 0.1 | 0.4 | 0.2 | - | - | - | - | ||
PEG |
0.25 | 0.12 | 0.06 | -0.05 | -0.01 | 0.47 | -0.02 | -0.01 | 0.01 | - | - | - | - |
P/B |
4.7 | 1.4 | 1.2 | 1.6 | -15.1 | 0.1 | 0.2 | 0.1 | 0.1 | - | - | - | - |
P/CF |
-11.4 | -5.5 | -1.8 | -3.5 | -0.3 | -0.2 | -0.3 | -0.2 | -0.2 | - | - | - | - |
ROE % |
-45.21 | -31.88 | -78.61 | -47.36 | 6542.65 | -65.80 | -66.52 | -47.55 | -43.93 | - | - | - | - |
ROA % |
-38.51 | -27.97 | -64.37 | -40.58 | -56.24 | -50.40 | -49.31 | -43.97 | -39.28 | - | - | - | - |
ROCE % |
-51.10 | -32.94 | -78.35 | -44.73 | -66.61 | -56.36 | -53.96 | -47.83 | -42.77 | - | - | - | - |
Current Ratio |
6.7 | 8.2 | 5.5 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | 11.4 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Larimar Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.21 | -0.19 | -0.15 | - | -0.37 | -0.47 | -0.49 | - | -0.92 | -0.79 | -0.76 | - | -0.64 | -1.21 | -1.1 | -0.19 | -1.42 | -0.61 | -0.35 | -0.39 | -0.41 | -0.57 | -0.58 | -0.48 | -0.46 | -0.49 | -0.48 | -0.38 | -0.54 | -0.55 | -0.65 | -0.85 | -0.73 | -0.66 | -0.53 | -0.48 | -0.65 | -2.96 | -6.18 | -5.35 | -4.88 | -4.37 | -4.94 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.17 | - | -0.37 | -0.46 | -0.48 | - | -0.9 | -0.77 | -0.75 | - | -0.64 | -1.21 | -1.09 | - | -1.41 | -0.6 | -0.35 | - | -0.41 | -0.56 | -0.57 | - | -0.46 | -0.49 | -0.48 | - | -0.54 | -0.55 | -0.65 | - | -0.73 | -0.65 | -0.52 | - | -0.63 | -2.75 | -6.19 | - | -4.82 | -4.07 | - | - | - | - | - | - | - | - | - |
ROE % |
-31.30 | -28.54 | -37.48 | -39.99 | -63.31 | -79.61 | -80.97 | -57.33 | -68.79 | -56.93 | -50.88 | -31.53 | 1013.28 | 2267.97 | 2814.32 | 2812.95 | 1268.14 | 8.75 | -541.88 | -550.17 | -66.90 | -66.84 | -66.99 | -66.52 | -58.36 | -54.33 | -49.61 | -47.55 | -52.68 | -52.38 | -50.53 | -43.93 | -40.69 | -43.00 | -38.62 | -34.93 | -18.77 | 0.40 | 11.10 | 15.37 | 9.68 | 4.57 | - | - | - | - | - | - | - | - | - |
ROA % |
-27.95 | -25.49 | -31.79 | -32.60 | -51.71 | -64.57 | -66.36 | -47.69 | -57.50 | -48.20 | -43.45 | -27.01 | -166.43 | -322.50 | -382.90 | -382.38 | -254.93 | -101.41 | -43.15 | -50.40 | -50.84 | -50.39 | -50.08 | -49.31 | -44.84 | -44.06 | -42.83 | -43.97 | -48.30 | -47.66 | -45.63 | -39.28 | -36.33 | -38.31 | -34.37 | -31.04 | -31.96 | -28.65 | -31.43 | -27.63 | -17.41 | -8.22 | - | - | - | - | - | - | - | - | - |
ROCE % |
-35.14 | -31.16 | -38.89 | -40.09 | -63.31 | -79.35 | -80.57 | -57.16 | -68.68 | -56.99 | -51.12 | -31.67 | 1211.55 | 2466.31 | 3012.73 | 1752.19 | 1735.92 | 476.43 | -73.97 | -49.78 | -66.20 | -66.35 | -66.97 | -50.68 | -62.86 | -58.63 | -53.70 | -39.23 | -50.89 | -50.36 | -48.40 | -29.90 | -43.65 | -45.74 | -41.06 | -23.81 | -18.67 | 0.22 | 10.29 | 9.48 | 9.48 | 4.34 | - | - | - | - | - | - | - | - | - |
Current Ratio |
9.2 | 9.5 | 9.4 | 8.2 | 9.3 | 4.9 | 5.0 | 5.5 | 5.5 | 6.0 | 6.5 | 7.0 | 7.0 | 7.0 | 7.0 | 0.9 | 0.9 | 0.9 | 3.0 | 4.3 | 4.3 | 4.3 | 4.3 | 3.9 | 3.9 | 3.9 | 3.9 | 13.3 | 13.3 | 13.3 | 13.3 | 9.5 | 9.5 | 9.5 | 9.5 | 9.0 | 9.0 | 9.0 | 9.0 | 13.1 | 13.1 | 13.1 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD